Harrison.ai, a Sydney-based startup, has raised $112 million in Series C funding to expand its AI diagnostic tools for medical imaging, including CT scans and X-rays. Their products, Annalise.ai and Franklin.ai, aim to assist medical professionals by improving the accuracy and efficiency of diagnoses. The use of AI technology is seen as crucial for early detection of diseases, which can expedite treatment and improve patient outcomes. Prominent investors include Aware Super and ECP Asset Management.
"Harrison's solutions also act as a second pair of eyes for radiologists and pathologists, enhancing workflow efficiency while reducing misdiagnosis risks for cancer and other critical illnesses."
Collection
[
|
...
]